Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry

By sjmartinez • May 21, 2024

Larsen CP, Vincenti F, D Kou T, Shadur CA, Bresnahan B, Jordan SC, Woodle ES, Goes N, Vella J, Wojciechowski D, Polinsky MS, Gomez-Caminero A. Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry. Transplant Direct. 2024 May 17;10(6):e1644. doi: 10.1097/TXD.0000000000001644. PMID: 38769981; PMCID: PMC11104716.

Tags: Cedars Sinai DoM, Nephrology, Publications

Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease

Tjoe B, Pacheco C, Suppogu N, Samuels B, Rezaeian P, Tamarappoo B, Berman DS, Sharif B, Nelson M, Anderson RD, Petersen J, Pepine CJ, Thomson[...]

Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography

Han D, Tzolos E, Park R, Gransar H, Hyun M, Friedman JD, Hayes SW, Thomson LEJ, Kwan AC, Budoff M, Shah PK, Kwieciński J, Wetzel[...]

A randomized controlled trial of meditation and health education on carotid intima-media thickness and major adverse cardiovascular events in Black men and women

Norris KC, Salerno J, Bairey Merz CN, Kaushik V, Gelleta S, Castillo A, Nidich S, Gaylord-King C, Schneider RH. A randomized controlled trial of meditation[...]